The efficacy and safety of the combination of anti-BRAF agent and MEK inhibitor in advanced melanoma patients with BRAF V600 mutation: A meta-analysis.

Changqing Xie,Basem M. Mishriky,Phillip Chae,Prashanti Atluri

The efficacy and safety of the combination of anti-BRAF agent and MEK inhibitor in advanced melanoma patients with BRAF V600 mutation: A meta-analysis.

2015

Changqing Xie
Basem M. Mishriky
Phillip Chae
Prashanti Atluri

e20006 Background: The combination of anti-BRAF agent and MEK inhibitor has been shown to improve outcomes for advanced melanoma patients with BRAF V600E mutation. A meta-analysis was performed to ...

Keywords:

Meta-analysis
Melanoma
MEK inhibitor
Cancer research
BRAF V600 Mutation
Medicine
BRAF V600E
Mutation
advanced melanoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations